Brainomix Extends Series C Financing to $25.4M (£18.8M) to Support U.S. Expansion

Brainomix has extended its Series C round to $25.4M (£18.8M) to support U.S. expansion. The additional funding will enhance Brainomix's industry-leading customer support and fast-track product advancements across its Brainomix 360 Stroke and e-Lung AI imaging platforms. The extension was led by existing investors Parkwalk and Hostplus, with participation from new U.S.-based investor Modi Ventures.